|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 50 studies with search of: | neurofibromatosis |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I
|
||||
| 2 | Active, not recruiting |
Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
|
||||
| 3 | Active, not recruiting |
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
|
||||
| 4 | Recruiting |
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
|
||||
| 5 | Suspended |
Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
|
||||
| 6 | Recruiting |
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
|
||||
| 7 | Recruiting |
Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
|
||||
| 8 | Completed |
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
|
||||
| 9 | Recruiting |
PTC299 for Treatment of Neurofibromatosis Type 2
|
||||
| 10 | Recruiting |
Sirolimus in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed By Surgery
|
||||
| 11 | Active, not recruiting |
Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
|
||||
| 12 | Recruiting |
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
|
||||
| 13 | Recruiting |
NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
|
||||
| 14 | Recruiting |
PEG-Interferon Alfa-2b in Treating Young Patients With Unresectable Plexiform Neurofibromas Associated With Neurofibromatosis Type 1
|
||||
| 15 | Recruiting |
Natural History Study of Patients With Neurofibromatosis Type I
|
||||
| 16 | Recruiting |
Sorafenib in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
|
||||
| 17 | Active, not recruiting |
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
|
||||
| 18 | Recruiting |
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
|
||||
| 19 | Recruiting |
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
|
||||
| 20 | Completed |
Quality of Friendships in Children With Neurofibromatosis
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|